Cardiovascular Research Institute, Department of Internal Medicine, The University of Kansas Medical Center, Kansas City, KS, USA.
The Schiefelbusch Institute for Lifespan Studies, The University of Kansas-Lawrence, Lawrence, KS, USA.
J Appl Res Intellect Disabil. 2018 Jan;31 Suppl 1:82-96. doi: 10.1111/jar.12348. Epub 2017 Mar 23.
The prevalence of obesity among individuals with intellectual and developmental disabilities (IDD) is equal to or greater than the general population.
Overweight/obese adults (BMI ≥25 kg/m ) with mild-to-moderate intellectual and developmental disabilities were randomized to an enhanced stop light diet (eSLD = SLD + portion-controlled meals, n = 78) or a conventional diet (CD, n = 72) for an 18 months trial (6 months weight loss, 12 months maintenance). Participants were asked to increase physical activity (150 min/week), self-monitor diet and physical activity and attend counselling/educational sessions during monthly home visits.
Weight loss (6 months) was significantly greater in the eSLD (-7.0% ± 5.0%) compared with the CD group (-3.8% ± 5.1%, p < .001). However, at 18 months, weight loss between groups did not differ significantly (eSLD = -6.7% ± 8.3%; CD = 6.4% ± 8.6%; p = .82).
The eSLD and CD provided clinically meaningful weight loss over 18 months in adults with intellectual and developmental disabilities.
智障和发育障碍(ID)人群的肥胖发生率与普通人群相等或更高。
将轻度至中度智障和发育障碍且超重/肥胖的成年人(BMI≥25kg/m )随机分配到强化信号灯饮食组(eSLD=SLD+控制份量的餐食,n=78)或常规饮食组(CD,n=72)进行为期 18 个月的试验(6 个月减肥,12 个月维持)。参与者被要求增加身体活动(150 分钟/周),自我监测饮食和身体活动,并在每月的家访中参加咨询/教育课程。
eSLD 组的体重减轻(6 个月)明显大于 CD 组(-7.0%±5.0%对-3.8%±5.1%,p<0.001)。然而,18 个月时,两组之间的体重减轻差异无统计学意义(eSLD=-6.7%±8.3%;CD=6.4%±8.6%;p=0.82)。
在智障和发育障碍的成年人中,eSLD 和 CD 在 18 个月内提供了具有临床意义的体重减轻。